Five years ago, 23andMe was one of the buzziest startups in the world. Now, 23andMe’s stock is worth less than $1. WSJ’s Rolfe Winkler unpacks the startup’s meteoric rise and fall. Further Reading and Watching: - 23andMe’s Fall From $6 Billion to Nearly $0 - How 23AndMe Went From a $6 Billion Valuation to a Penny Stock - 23andMe Mulls Possible Split, Shares Fall After Disappointing Results Learn more about your ad choices. Visit megaphone.fm/adchoices
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from The Journal.
Transcribed and ready to explore now
Medicare, Inc. Part 1: How Insurers Make Billions From Medicare
06 Jun 2025
The Journal.
Deportations Could Upend This Parachute Factory
05 Jun 2025
The Journal.
The Struggle to Get Aid Into Gaza
04 Jun 2025
The Journal.
The Everyday American Who Hustled for North Korea
03 Jun 2025
The Journal.
Stop Making Cents: The End of the Penny
02 Jun 2025
The Journal.
Ron Howard and Brian Grazer on Longevity in Hollywood
01 Jun 2025
The Journal.